2018 ACR/ARHP Annual Meeting

October 19-24, 2018. Chicago, IL.

View by Number View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n o p q r s t u v [w] x y z

Abstract Number: 503

Waist Circumference Based Abdominal Obesity Versus Body Mass Index in Rheumatoid Arthritis: Influence on the Risk of Diabetes and Cardiovascular Disease
Abstract Number: 2927

What Are the Optimal MRI Lesion Cut-Offs That Define Active and Structural Lesions in the Sacroiliac Joint As Being Typical of Axial Spondyloarthritis By Expert Readers?
Abstract Number: 2241

What Can Variation in Clinical Practice Teach Us about Treatment Strategies for Patients with Gout?
Abstract Number: 438

What Characterizes Osteoarthritis: Ultrasound-Detected Inflammation but Not Osteophytes Is More Common in Hand Osteoarthritis Than in Painless Bony Enlargements
Abstract Number: 1273

What Did Patients from the US Think about Their Gout in 2017?
Abstract Number: 1739

What Do Patient Reported Outcomes for Routine Monitoring of Gastrointestinal Tract Symptoms in a Systemic Sclerosis Center Tell Us about Clinical Features of Potential Small Intestinal Bacterial Overgrowth?
Abstract Number: 421

What Do Patients with Osteoarthritis Think of Their Preoperative Education before Total Hip Replacement Surgery:Qualitative Study
Abstract Number: 2693

What Is the Effect of Cyclophosphamide Iv Pulse Therapy in Patients with Diffuse Cutaneous Systemic Sclerosis on Skin Involvement: An Observational Study
Abstract Number: 968

What Is the Impact of Imaging on Diagnostic Ascertainment of Patients Presenting with Undiagnosed Back Pain in Routine Practice and the Impact of Central Reading? Data from the Screening in Axial Spondyloarthritis in Psoriasis, Iritis, and Colitis Cohort
Abstract Number: 656

What Is the Level of Agreement between Local and Central Readers in the Detection of Active and Structural MRI Lesions Typical of Axial Spondyloarthritis? Data from the Assessments in Spondyloarthritis Classification Cohort Study
Abstract Number: 1237

What Is the Value of Synovial Biopsies for the Diagnosis of Septic Arthritis?
Abstract Number: 2227

What Should be the Goals of Gout Therapy? a Patient Perspective
Abstract Number: 2375

When Are People Receptive to Self Management Education Information, and What Information Appeals to Them? : An Analysis of Digital Data
Abstract Number: 1658

Which Factors Influence the Diagnostic Delay in Patients with Axial Spondyloarthritis?
Abstract Number: 2477

Which Is the Best Measure for Rheumatoid Arthritis Disease Activity? a Head to Head Comparison of the Six American College of Rheumatology Recommended Disease Activity Measures
Abstract Number: 2926

Which MRI Lesions in the Sacroiliac Joint Are Associated with the Diagnosis of Axial Spondyloarthritis after 2 Years Follow up in the Echography in Spondyloarthritis Cohort?
Abstract Number: 76

Whole Blood Targeted Bisulfite Pyrosequencing Identifies Differentially Methylated Regions within Major Histocompatibility Complex (MHC) of Patients with Rheumatoid Arthritis
Abstract Number: 2027

Whole Exome Trio Sequencing Implicates DOCK2 in Juvenile Idiopathic Arthritis
Abstract Number: 228

Widespread Chronic Use of Proton-Pump Inhibitors and Potential for Drug-Drug Interactions in Rheumatoid Arthritis and Lupus Patients
Abstract Number: 2468

Window or No Window? Earlier Is Better When Treating Rheumatoid Arthritis
Abstract Number: 835

WITHDRAWN
Abstract Number: 1175

Withdrawn
Abstract Number: 1184

Withdrawn
Abstract Number: 1640

Work Disability in Psoriatic Arthritis Patients
Abstract Number: 1156

Work Productivity and Activity Impairment in Patients with Rotator Cuff Tendinopathy
Abstract Number: 1792

Work Productivity Is Impaired in Patients with Behcet’s Syndrome
Abstract Number: 2177

Workforce Requirements in Rheumatology: A Systematic Literature Reviewinforming the Development of a Workforce Prediction Risk of Bias Tool and the EULAR Points to Consider

Jump to: View All • a b c d e f g h i j k l m n o p q r s t u v [w] x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].